GlassScriptPhysician profile
Anna Haralson Powell
NPI 1255038469
$889.36
in general payments reported to CMS, 2019-2025
11 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $38.09 · 2024: $330 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $370.90 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $189.83 | 2024-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $99.31 | 2024-2025 | |
| Philips North America LLC | $53.81 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Actelion Pharmaceuticals US, INC. | $52.02 | 2024-2025 | Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.95 | 2024 | Jardiance |
| Scpharmaceuticals INC. | $23.95 | 2023 | |
| Glaxosmithkline, LLC. | $18.16 | 2025 | Shingrix, Arexvy |
| Boston Scientific Corporation | $17.57 | 2025 | Watchman Flx |
| Pfizer INC. | $16.72 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $14.14 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.